Beneficial effects of zoledronate compared to placebo on spine bone mineral density (BMD) and microarchitecture (TBS) parameters in postmenopausal women with osteoporosis: a 3-year study

---

Autoria(s): Popp A.W.; Buffat H.; Lamy O.; Perrelet R.; Hans D.; Lippuner K.

Data(s)	2012
Identificador	http://serval.unil.ch/?id=serval:BIB_815F311C58D5 isbn:0937-941X isiid:000309259600542
Idioma(s)	en
Fonte	IOF-ECCEO 2012, 2nd European Congress on Osteoporosis and Osteoarthritis
Tipo	info:eu-repo/semantics/conferenceObject inproceedings